Agilent Technologies, Inc. (NYSE:A) Shares Sold by Grimes & Company Inc.

Grimes & Company Inc. lessened its stake in shares of Agilent Technologies, Inc. (NYSE:A) by 8.2% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 93,340 shares of the medical research company’s stock after selling 8,289 shares during the quarter. Grimes & Company Inc.’s holdings in Agilent Technologies were worth $13,859,000 at the end of the most recent reporting period.

A number of other hedge funds have also made changes to their positions in the stock. International Assets Investment Management LLC acquired a new position in shares of Agilent Technologies during the third quarter valued at approximately $12,961,000. McAdam LLC increased its stake in shares of Agilent Technologies by 3.1% during the third quarter. McAdam LLC now owns 2,531 shares of the medical research company’s stock valued at $376,000 after acquiring an additional 77 shares during the period. Commerzbank Aktiengesellschaft FI bought a new stake in Agilent Technologies during the third quarter worth approximately $271,000. Weaver Capital Management LLC bought a new stake in Agilent Technologies during the third quarter worth approximately $490,000. Finally, Eastern Bank bought a new stake in Agilent Technologies during the third quarter worth approximately $15,818,000. Institutional investors and hedge funds own 87.42% of the company’s stock.

Wall Street Analyst Weigh In

A number of brokerages recently weighed in on A. Bank of America raised their target price on shares of Agilent Technologies from $140.00 to $147.00 and gave the stock a “neutral” rating in a report on Thursday, August 22nd. Citigroup raised their price objective on shares of Agilent Technologies from $150.00 to $165.00 and gave the stock a “buy” rating in a research note on Thursday, August 22nd. UBS Group lifted their target price on shares of Agilent Technologies from $141.00 to $150.00 and gave the company a “neutral” rating in a research note on Thursday, August 22nd. Wells Fargo & Company started coverage on shares of Agilent Technologies in a research note on Tuesday, August 27th. They set an “overweight” rating and a $157.00 target price for the company. Finally, Stifel Nicolaus reissued a “buy” rating and set a $151.00 target price on shares of Agilent Technologies in a research note on Monday, August 26th. One analyst has rated the stock with a sell rating, five have given a hold rating and nine have issued a buy rating to the company’s stock. According to data from MarketBeat.com, Agilent Technologies currently has a consensus rating of “Moderate Buy” and a consensus price target of $144.36.

Insider Buying and Selling at Agilent Technologies

In other news, CEO Padraig Mcdonnell sold 1,958 shares of the company’s stock in a transaction that occurred on Friday, July 26th. The shares were sold at an average price of $140.00, for a total value of $274,120.00. Following the completion of the transaction, the chief executive officer now owns 26,076 shares in the company, valued at $3,650,640. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. In related news, CEO Padraig Mcdonnell sold 1,958 shares of the stock in a transaction on Friday, July 26th. The shares were sold at an average price of $140.00, for a total transaction of $274,120.00. Following the completion of the transaction, the chief executive officer now owns 26,076 shares in the company, valued at approximately $3,650,640. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, SVP Dominique Grau sold 9,990 shares of the stock in a transaction on Thursday, September 26th. The stock was sold at an average price of $145.00, for a total transaction of $1,448,550.00. Following the transaction, the senior vice president now owns 40,011 shares of the company’s stock, valued at $5,801,595. The trade was a 0.00 % decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 13,953 shares of company stock valued at $2,013,630. Corporate insiders own 0.33% of the company’s stock.

Agilent Technologies Price Performance

Shares of NYSE A traded down $0.38 during trading on Thursday, reaching $132.65. The company had a trading volume of 27,529 shares, compared to its average volume of 1,678,490. Agilent Technologies, Inc. has a 52 week low of $96.80 and a 52 week high of $155.35. The stock has a market cap of $38.70 billion, a PE ratio of 31.45, a PEG ratio of 6.96 and a beta of 1.05. The company has a debt-to-equity ratio of 0.36, a quick ratio of 1.37 and a current ratio of 1.78. The business’s 50 day moving average price is $140.91 and its 200-day moving average price is $138.59.

Agilent Technologies (NYSE:A) last posted its quarterly earnings results on Wednesday, August 21st. The medical research company reported $1.32 earnings per share for the quarter, topping analysts’ consensus estimates of $1.26 by $0.06. The business had revenue of $1.58 billion during the quarter, compared to the consensus estimate of $1.56 billion. Agilent Technologies had a net margin of 21.75% and a return on equity of 25.26%. Agilent Technologies’s revenue for the quarter was down 5.6% compared to the same quarter last year. During the same period in the previous year, the firm posted $1.43 earnings per share. Analysts expect that Agilent Technologies, Inc. will post 5.24 earnings per share for the current year.

Agilent Technologies Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Wednesday, October 23rd. Shareholders of record on Tuesday, October 1st were paid a $0.236 dividend. This represents a $0.94 annualized dividend and a yield of 0.71%. The ex-dividend date was Tuesday, October 1st. Agilent Technologies’s payout ratio is presently 22.22%.

Agilent Technologies Company Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.